Navigation Links
Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018 - Transparency Market Research

Albany, New York (PRWEB) July 07, 2013

According to a new market report published by Transparency Market Research “Synthetic Biology Market, Global Industry Analysis, Size, Growth, Share and Forecast, 2012 – 2018?, global Synthetic biology market was worth USD 1,537.5 million in 2011.

The market grew to a value of USD 2,120 million in 2012, and is expected to reach USD 16,745 million by 2018, growing at a CAGR of 41.1% from 2010 to 2018. In the overall global market, Europe holds the maximum market share, and is expected to maintain its lead position in terms of revenue till 2018.

Related Report : Nanobiotechnology Market

The global Synthetic biology market is driven by factors such as increasing incidence of oceanic oil spills and other types of pollutions, potential substitute of genetic engineering, increasing demand for cross bred animals, dropping prices of DNA sequencing and DNA synthesis, increasing population is increasing the demand for GM (Genetically Modified) food, increasing demand for alternative energy resources like biofuels, and rising R&D investments in drug development.

Some of the opportunities in the synthetic biology market which would drive the revenue of the industry in the future include rising economies of Asia Pacific regions and the BRICS nations, and increasing investments of WHO and other NGOs in third world countries to fight epidemic diseases such as malaria.

Related Report : Hepatitis Diagnostic Market

Europe holds the maximum market share in the synthetic biology market, owing to high demand of synthetic biology products like biofuels and increasing R&D activities in the field of synthetic biology. The Europe synthetic biology market was valued at USD 619.5 million in the year 2011, and is expected to grow at a CAGR of 39.8% from 2012 to 2018, to reach USD 6,389.5 million by the year 2018.

The synthetic biology market can be segmented into 4 major categories: synthetic biology market by products, synthetic biology market by enabled product application, synthetic biology technology by enabling technology and synthetic biology by geography. The global synthetic biology market by enabling technology was valued at USD 183.84 million and is expected to grow at a CAGR of 44.7% from 2012 to 2018, to reach an estimated value of USD 1780.40 million by 2018.

Some of the key market players in the synthetic biology market are NEB, Amyris Biotechnology Inc, Blue Heron Biotechnology Inc, Chromatin, Febit Symbio GmbH, Gene Art-Life Science Technologies, Synthetic Genomics, Verdezyne Inc, New England Biolabs Inc, and others.

This research is specially designed to estimate and analyze the demand and performance of synthetic biology products in global scenario. This research provides in-depth analysis of Synthetic biology product manufacturers, product sales, trend analysis by segments and demand by geography.

Browse Bolg : Business Research Industry

The report covers all the major product segments of the global Synthetic biology market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global Synthetic biology market as below:

Synthetic Biology Market by Products

  • Enabling Products

Synthetic Biology Enabled Products by Application

  • Chemicals and Energy Market
  • Diagnostics and Pharmaceutical Market
  • Biofuels Market

Synthetic Biology Market by Enabling Technologies

  • Synthetic Biology Enabling Technology
  • Synthetic Biology Enabling Technologies, Market Overview
  • DNA Sequencing Technologies
  • Bioinformatics Technologies
  • Biological Components and Integrated Systems Applications
  • Genome Engineering

Browse the full report with TOC at :

In addition the report provides a cross-sectional analysis of all the above segments with respect to the North America, Europe and Asia Pacific regions.

The in-depth research and high level analysis will allow synthetic biology product manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about synthetic biology products manufacturing, designing marketing, growth strategies and gaining competitive advantage.

Browse All Market Research Reports:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Employers Now Able to Test for Synthetic Marijuana
2. Public Voting Opens for Finalists in Synthetic Turf International’s Better Play & Recreation Contest
3. Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates
4. Synthetic Pot Use Can Mimic Symptoms of Prenatal Disorder
5. Fluoride Treatment of Synthetic Bio-material Assists Dental Bone Regeneration
6. Temple scientists weaken HIV infection in immune cells using synthetic agents
7. 16 Cases of Kidney Damage in 6 States From Synthetic Pot: CDC
8. Synthetic Marijuana Use Linked to Kidney Damage
9. Synthetic circuit allows dialing gene expression up or down in human cells
10. Synthetic corkscrew peptide kills antibiotic-resistant Gram-negative bacteria
11. Strange behavior: New study exposes living cells to synthetic protein
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
(Date:11/25/2015)... , ... November 25, 2015 , ... For the first ... “ Two Organizations, One Beat ” campaign. The partnership between the two groups began ... aid in MAP International’s cause. , MAP International was founded in 1954 and is ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Smiles by ... TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the ... the great success Botox® delivers to those suffering with discomfort, soreness, and pain as ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 USP ... hazardous drug preparations (e.g. pharmacists, pharmacy technicians, nurses, ... veterinary technicians). The chapter also covers all entities ... (e.g., pharmacies, hospitals, other healthcare institutions, patient treatment ... --> --> What ...
(Date:11/25/2015)... 25, 2015 Asia ... which BioLight and the New Investors will make a ... via a private placement. The financing will help IOPtima ... system used in the treatment of glaucoma, as well ... the IOPtimate™ system with the U.S. Food and Drug ...
(Date:11/25/2015)... LONDON , November 25, 2015 Developmental, ... key role in boosting the profitability of pharmaceutical products, ... Developmental, commercial, and regulatory/legal strategies all play ... says GBI Research . --> ... all play a key role in boosting the profitability of pharmaceutical ...
Breaking Medicine Technology: